Status and phase
Conditions
Treatments
About
The goal of this study is to test cannabidiol (CBD) as a potentially effective candidate medication for youth alcohol use disorder (AUD). To accomplish this goal, this study will use a randomized, double-blind, within-subjects crossover design. In counterbalanced order, 50 youth (ages 16-22) will receive 600 mg of CBD or placebo three hours before a neuroimaging and behavioral assessment paradigm. The total amount of time the participant will be in the study is approximately one month.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Age 16 to 22. Does or does not drink alcohol.
Primary purpose
Allocation
Interventional model
Masking
36 participants in 2 patient groups
Loading...
Central trial contact
Cori Herring, BS; Lindsay Squeglia, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal